These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 10710207

  • 1. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Røsok BI, Olofsson J, Asjö B.
    AIDS Res Hum Retroviruses; 2000 Feb 10; 16(3):191-201. PubMed ID: 10710207
    [Abstract] [Full Text] [Related]

  • 2. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Olofsson J, Asjö B.
    AIDS; 1999 Dec 03; 13(17):2365-76. PubMed ID: 10597778
    [Abstract] [Full Text] [Related]

  • 3. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 4. Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy.
    Voltersvik P, Dyrhol-Riise AM, Bostad L, Røsok BI, Olofsson J, Asjö B.
    APMIS; 2000 May 01; 108(7-8):539-50. PubMed ID: 11167551
    [Abstract] [Full Text] [Related]

  • 5. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
    Evans TG, Bonnez W, Soucier HR, Fitzgerald T, Gibbons DC, Reichman RC.
    Antiviral Res; 1998 Oct 01; 39(3):163-73. PubMed ID: 9833957
    [Abstract] [Full Text] [Related]

  • 6. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
    Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP.
    AIDS Res Hum Retroviruses; 2002 Jan 20; 18(2):95-102. PubMed ID: 11839142
    [Abstract] [Full Text] [Related]

  • 7. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R, Kinloch S, Goh LE, Cooper D, Perrin L, Lampe F, Zaunders J, Hoen B, Tsoukas C, Andersson J, Janossy G, Quest Study Group.
    AIDS; 2002 Mar 08; 16(4):589-96. PubMed ID: 11873002
    [Abstract] [Full Text] [Related]

  • 8. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ, Cunningham PH, Kelleher AD, Kaufmann GR, Jaramillo AB, Wright R, Smith D, Grey P, Vizzard J, Carr A, Cooper DA.
    J Infect Dis; 1999 Aug 08; 180(2):320-9. PubMed ID: 10395845
    [Abstract] [Full Text] [Related]

  • 9. Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.
    Dyrhol-Riise AM, Voltersvik P, Berg OG, Olofsson J, Kleivbo S, Asjö B.
    AIDS Res Hum Retroviruses; 2001 May 01; 17(7):577-86. PubMed ID: 11375053
    [Abstract] [Full Text] [Related]

  • 10. Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.
    García F, Alonso MM, Romeu J, Knobel H, Arrizabalaga J, Ferrer E, Dalmau D, Ruiz I, Vidal F, Frances A, Segura F, Gomez-Sirvent JL, Cruceta A, Clotet B, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.
    J Acquir Immune Defic Syndr; 2000 Sep 01; 25(1):26-35. PubMed ID: 11064501
    [Abstract] [Full Text] [Related]

  • 11. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
    Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A.
    AIDS; 2000 May 05; 14(7):761-70. PubMed ID: 10839583
    [Abstract] [Full Text] [Related]

  • 12. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
    Plana M, Ferrer E, Martínez C, Podzamczer D, García F, Maleno MJ, Barceló JJ, García A, Barberá MJ, Lacarcel M, Miró JM, Gallart T, Gatell JM.
    Antivir Ther; 2004 Apr 05; 9(2):197-204. PubMed ID: 15134181
    [Abstract] [Full Text] [Related]

  • 13. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
    Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St Clair M, Kotzin BL, Fox L, Chiozzi MH, Leonard JM, Rousseau F, Wade M, Roe JD, Martinez A, Kessler H.
    J Infect Dis; 1998 Jul 05; 178(1):70-9. PubMed ID: 9652425
    [Abstract] [Full Text] [Related]

  • 14. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.
    AIDS; 2000 Sep 08; 14(13):1921-33. PubMed ID: 10997396
    [Abstract] [Full Text] [Related]

  • 15. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J.
    Science; 1997 Jul 04; 277(5322):112-6. PubMed ID: 9204894
    [Abstract] [Full Text] [Related]

  • 16. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ, Begovac J, Vince A.
    FEMS Immunol Med Microbiol; 2006 Apr 04; 46(3):351-9. PubMed ID: 16553807
    [Abstract] [Full Text] [Related]

  • 17. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.
    Lederman MM, McKinnis R, Kelleher D, Cutrell A, Mellors J, Neisler M, Cooney E, Haas DW, Haubrich R, Stanford J, Horton J, Landay A, Spreen W.
    AIDS; 2000 Dec 01; 14(17):2635-42. PubMed ID: 11125881
    [Abstract] [Full Text] [Related]

  • 18. [A clinical trial using zidovudine and lamivudine plus indinavir triple therapy in Chinese individuals with human immunodeficiency virus infection].
    Cao Y, Zhang F, Mei S, Li L, Gao M, Ding Y, Cai W.
    Zhonghua Nei Ke Za Zhi; 2002 Feb 01; 41(2):109-13. PubMed ID: 11940307
    [Abstract] [Full Text] [Related]

  • 19. Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals.
    Dyrhol-Riise AM, Brantsaeter AB, Dunlop O, Baklien K, Skar AG, Asjö B, Bruun JN, Røsok BI.
    Scand J Immunol; 2000 Feb 01; 51(2):195-201. PubMed ID: 10652164
    [Abstract] [Full Text] [Related]

  • 20. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.
    Rinaldo CR, Huang XL, Fan Z, Margolick JB, Borowski L, Hoji A, Kalinyak C, McMahon DK, Riddler SA, Hildebrand WH, Day RB, Mellors JW.
    J Virol; 2000 May 01; 74(9):4127-38. PubMed ID: 10756025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.